The clinical and survival benefit of home oxygen therapy, both LTOT and nocturnal oxygen therapy, for patients with COPD and moderate hypoxemia was evaluated in this meta-analysis. Home oxygen therapy ...

Nevertheless, further studies were validated not only because there were indications that a subset of patients with moderately severe COPD might have benefitted by oxygen supplementation but also ...

Please provide your email address to receive an email when new articles are posted on . The addition of high-flow nasal cannula to long-term oxygen therapy may ...

The high flow oxygen therapy (HFOT) market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This growth is primarily driven by the ...

Individuals with chronic obstructive pulmonary disease (COPD) experience improved breathing symptoms and dyspnea with use of automated oxygen administration. Automated oxygen administration (AOA) was ...

Please provide your email address to receive an email when new articles are posted on . This study investigated the 2011 and 2013 implementation of the Competitive Bidding Program (CBP). Supplemental ...

The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...

The Medicare Competitive Bidding Program (CBP) appeared to reduce spending without impacting oxygen prescriptions for beneficiaries with chronic obstructive pulmonary disease (COPD), a study showed.

Long-term oxygen therapy improves survival outcomes in patients with COPD, but those who have nocturnal arterial oxygen desaturation but not severe daytime hypoxemia do not currently qualify for such ...

Using two asthma drugs as combined therapy reduces mortality among patients with chronic obstructive pulmonary disease (COPD) more than one drug alone, according to the largest COPD trial ever done.